CETTA, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 704
NA - Nord America 574
AS - Asia 542
SA - Sud America 99
AF - Africa 15
Totale 1.934
Nazione #
US - Stati Uniti d'America 545
RU - Federazione Russa 438
SG - Singapore 201
CN - Cina 151
IT - Italia 114
BR - Brasile 79
HK - Hong Kong 63
VN - Vietnam 53
DE - Germania 28
FR - Francia 22
GB - Regno Unito 22
FI - Finlandia 21
IN - India 20
CA - Canada 18
SE - Svezia 17
MX - Messico 10
JP - Giappone 9
PL - Polonia 9
AR - Argentina 8
NL - Olanda 8
TR - Turchia 8
BD - Bangladesh 7
EC - Ecuador 6
ES - Italia 6
ZA - Sudafrica 6
ID - Indonesia 5
IQ - Iraq 4
IR - Iran 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CH - Svizzera 3
CO - Colombia 3
IE - Irlanda 3
NP - Nepal 3
SA - Arabia Saudita 3
UA - Ucraina 3
ZW - Zimbabwe 3
BG - Bulgaria 2
LB - Libano 2
PK - Pakistan 2
VE - Venezuela 2
AT - Austria 1
BW - Botswana 1
DZ - Algeria 1
GH - Ghana 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
NG - Nigeria 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
Totale 1.934
Città #
Dallas 151
Singapore 128
Ashburn 69
Moscow 67
Hong Kong 62
New York 39
San Jose 36
Beijing 34
Milan 25
Ho Chi Minh City 20
Hefei 18
Los Angeles 18
Shanghai 18
Lauterbourg 17
Orem 13
Council Bluffs 12
Boardman 11
Florence 11
Nuremberg 10
São Paulo 10
Turku 10
Denver 9
Munich 9
Warsaw 9
Santa Clara 8
Tokyo 8
Ankara 7
Hanoi 7
Montreal 7
Chennai 6
Houston 6
Helsinki 5
Lappeenranta 5
Mexico City 5
Poplar 5
Rho 5
Rome 5
Amsterdam 4
Atlanta 4
Coimbatore 4
Johannesburg 4
Manchester 4
Phoenix 4
Seattle 4
Stockholm 4
Tehran 4
Toronto 4
Washington 4
Belo Horizonte 3
Bologna 3
Brussels 3
Da Nang 3
Dublin 3
Falkenstein 3
Hackney 3
Harare 3
Latina 3
Lawrence 3
Perugia 3
Princeton 3
Quito 3
Baghdad 2
Barcelona 2
Betim 2
Biên Hòa 2
Brooklyn 2
Charlotte 2
Curitiba 2
Ferrara 2
Frankfurt am Main 2
Hải Dương 2
Itaúna 2
Jeddah 2
Jiaxing 2
Limeira 2
Medellín 2
Miami 2
Mumbai 2
Nantong 2
Naples 2
New Delhi 2
Ottawa 2
Pescara 2
Pune 2
Recife 2
San Cipriano d'Aversa 2
San Francisco 2
Sofia 2
Teixeira de Freitas 2
Thủ Đức 2
Tianjin 2
Turin 2
Xi'an 2
Zurich 2
Acarigua 1
Al Fujairah City 1
Alto Santo 1
Andradina 1
Annapolis 1
Arapiraca 1
Totale 1.040
Nome #
A novel scoring approach to identify responders to erenumab in clinical practice 181
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 142
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 116
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 112
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 108
Imaging the brain and vascular reactions to headache treatments: a systematic review 104
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 100
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 98
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 97
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) 89
Stress in paediatric migraine: a trigger factor? 84
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 83
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report 82
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 80
Tracking the evolution of non-headache symptoms through the migraine attack 79
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 71
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 70
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) 69
A novel scoring approach to identify responders to erenumab in clinical practice 62
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 61
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 52
Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report 52
EXPLORING THE CENTRAL EFFECT OF MONOCLONAL ANTIBODIES TARGETING THE CGRP PATHWAY IN MIGRAINE PATIENTS: A MULTIMODAL MRI STUDY 9
Exploring the role of the pons and hypothalamus in migraine progression 2
Exploring the role of the pons and hypothalamus in migraine progression 2
Totale 2.005
Categoria #
all - tutte 7.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 1 1 0 0 0 0 0 0 0 5 1
2022/202352 8 6 7 0 3 3 2 2 3 0 3 15
2023/2024161 7 16 16 14 13 27 3 16 4 4 19 22
2024/2025321 24 6 19 14 32 23 35 23 36 47 34 28
2025/20261.462 97 97 139 219 140 63 111 125 415 56 0 0
Totale 2.005